ADH1, an N-cadherin inhibitor, evaluated in preclinical models of angiogenesis and androgen-independent prostate cancer

Haiqing Li, Douglas K. Price, William D. Figg*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'ADH1, an N-cadherin inhibitor, evaluated in preclinical models of angiogenesis and androgen-independent prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences